Versuchen GOLD - Frei
Direct tax mop-up rises 8%, tax relief tempers growth
Mint Chennai
|December 20, 2025
Collections grow at slower than projected 13%; non-tax revenue robust on RBI dividend
Disinflation also affected tax revenue buoyancy. In the three months to November, CPI-based inflation was below RBI's target range of 2-6%.
(ISTOCKPHOTO)
The Centre’s direct tax revenue collection, after adjusting for refunds, stood at ₹17 trillion in the April to mid-December period, rising 8% year-on-year, official data showed.
The growth was slower than the projected 13% increase, as tax relief granted to individuals moderated revenue growth from personal income taxes. Data released by the Central Board of Direct Taxes (CBDT) on Friday showed that tax receipts from corporations and individuals between 1 April and 17 December accounted for two-thirds of the full-year target of ₹25.2 trillion.
Companies paid over ₹8.17 trillion during the period after adjusting for refunds, registering a 10.5% increase year-on-year, in line with the growth rate projected in the Union budget for FY26, presented on 1 February.
Individuals have paid about ₹8.47 trillion so far this financial year after adjusting for refunds, marking a 6.4% growth. However, this is slower than the 14.4% growth projected for net personal income tax receipts this year.
Diese Geschichte stammt aus der December 20, 2025-Ausgabe von Mint Chennai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
